OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism
Hui-Yun Chang, Tzu‐Kang Sang, Ann‐Shyn Chiang
Journal of Biomedical Science (2018) Vol. 25, Iss. 1
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases
Hao Ran, Hui-Yun Chang, Tzu‐Kang Sang
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3082-3082
Open Access | Times Cited: 337

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
Priyanka Rawat, Ujala Sehar, Jasbir Bisht, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12841-12841
Open Access | Times Cited: 183

Neuronal cell death mechanisms in Alzheimer’s disease: An insight
Parul Goel, Sasanka Chakrabarti, Kapil Goel, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 123

The function of gut microbiota in immune-related neurological disorders: a review
Panida Sittipo, Jae-Yoon Choi, Soojin Lee, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 96

Enhanced in Vivo Blood–Brain Barrier Penetration by Circular Tau–Transferrin Receptor Bifunctional Aptamer for Tauopathy Therapy
Xiaowei Li, Yu Yang, Hengzhi Zhao, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 8, pp. 3862-3872
Closed Access | Times Cited: 92

Insights into Disease-Associated Tau Impact on Mitochondria
Leonora Szabo, Anne Eckert, Amandine Grimm
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6344-6344
Open Access | Times Cited: 69

The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease
Dennison Trinh, Ahmad R. Israwi, Lindsay R. Arathoon, et al.
Journal of Neurochemistry (2020) Vol. 156, Iss. 6, pp. 715-752
Open Access | Times Cited: 61

Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
Sebastian Oakley, Mahmoud Bukar Maina, Karen E. Marshall, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 44

GABRB2, a key player in neuropsychiatric disorders and beyond
Manel Barki, Hong Xue
Gene (2021) Vol. 809, pp. 146021-146021
Closed Access | Times Cited: 36

mTOR signaling and Alzheimer's disease: What we know and where we are?
Samin Davoody, Afsaneh Asgari Taei, Pariya Khodabakhsh, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 15

Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers
Nicolò Bisi, Luca Pinzi, Giulio Rastelli, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 722-722
Open Access | Times Cited: 5

Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs
Yanxin Shen, Meng Zhao, Panpan Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5

NXP032 Improves Memory Impairment Through Suppression of Tauopathy in PS19 Mice and Attenuates Okadaic Acid-Induced Tauopathy in SH-SY5Y Cells
Hyeyoon Eo, Seong Hye Kim, In Gyoung Ju, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access

Phosphorylation-Induced Self-Coacervation versus RNA-Assisted Complex Coacervation of Tau Proteins
Mohammadreza Allahyartorkaman, Ting-Hsuan Chan, Hsin‐Liang Chen, et al.
Journal of the American Chemical Society (2025)
Closed Access

SUMO inhibits Tau aggregation in Alzheimer’s disease
Subashchandrabose Chinnathambi, Nagaraj Rangappa
Advances in protein chemistry and structural biology (2025)
Closed Access

Key Peptides and Proteins in Alzheimer’s Disease
Botond Penke, Ferenc Bogár, Gábor Paragi, et al.
Current Protein and Peptide Science (2019) Vol. 20, Iss. 6, pp. 577-599
Closed Access | Times Cited: 41

The Cytoskeleton as a Modulator of Aging and Neurodegeneration
Konstantinos Kounakis, Nektarios Tavernarakis
Advances in experimental medicine and biology (2019), pp. 227-245
Closed Access | Times Cited: 38

Fenamates as Potential Therapeutics for Neurodegenerative Disorders
Jaunetta Hill, Nasser H. Zawia
Cells (2021) Vol. 10, Iss. 3, pp. 702-702
Open Access | Times Cited: 25

Unravelling the mechanotransduction pathways in Alzheimer’s disease
Francesca Donnaloja, Emma Limonta, Christian Mancosu, et al.
Journal of Biological Engineering (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 10

Alzheimer’s disease: phenotypic approaches using disease models and the targeting of tau protein
Elisabetta Lauretti, Domenico Praticò
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 4, pp. 319-330
Open Access | Times Cited: 25

Retromer in Synaptic Function and Pathology
Lennart Brodin, Oleg Shupliakov
Frontiers in Synaptic Neuroscience (2018) Vol. 10
Open Access | Times Cited: 24

Page 1 - Next Page

Scroll to top